Malaysia Healthcare Travel Council (MHTC) today signed two Memorandums of Understanding (MoUs) with China’s International Medical Exchange & Cooperation Committee (IMECC) and Hangzhou Rende Maternity Hospital respectively with the aim to collaboratively improve the patient experience for healthcare travellers from China.
These partnerships will encourage knowledge exchange between IMECC and Hangzhou Rende Maternity Hospital with MHTC through a series of virtually conducted Continuous Medical Education (CME) sessions, whereby Malaysian and Chinese healthcare experts will explore and discuss industry best practices and healthcare matters. Additionally, the partnership with each respective entity will also open doors for patients from China to seek safe and trusted treatment options with Malaysia Healthcare through consultations with their doctors at home.
“Through our partnerships with IMECC and Hangzhou Rende Maternity Hospital, we are confident that healthcare travellers from China will benefit from a more holistic patient journey experience which offers continuity of care with excellent pre and post care services. I look forward to the knowledge exchange sessions as this will strengthen our reputation for delivering world-class quality healthcare services which exemplifies patient trust and caters to the ever-changing healthcare traveller needs,” said Mohd Daud Mohd Arif, Chief Executive Officer of MHTC.
Malaysia is an increasingly preferred healthcare destination for healthcare travellers from China, particularly since Malaysia has been positioned regionally as the Fertility Hub of Asia and has experienced a 300% increase in demand for fertility treatments between 2011 to 2016. By the same token, Malaysia has also been positioned as the Cardiology Hub of Asia, being home to highly reputable cardio health institutions which have achieved many breakthroughs in the field of cardiology. Moving forward, Malaysia will also be showcased as the Cancer Centre of Excellence.
“IMECC is pleased to partner with MHTC, the government agency that promotes the country’s healthcare travel industry, known as Malaysia Healthcare, around the globe. With the acknowledgement of Malaysia’s renowned reputation in providing fertility, cardiology, and oncology treatments, we hope to establish a long-term partnership where both countries’ medical experts can join forces and work towards medical and service excellence,” said Ching Manho, President of IMECC.
Ren Ding Xiang, Dean of Hangzhou Rende Maternity Hospital, shared that the institution will be working closely with the Hangzhou Malaysia International Referral Centre to ensure a seamless patient experience for those seeking additional treatment in Malaysia, “As a renowned private hospital that thrives on providing high quality fertility related services to our patients, Hangzhou Rende Maternity Hospital looks forward to embarking on a journey with Malaysia Healthcare to elevate our patients’ healthcare journey experience. We aim to provide patients a greater medical experience where they can get additional consultations from Malaysia’s healthcare experts.”
In July 2020, Malaysia was among the first countries to establish a medical travel bubble and began receiving healthcare travellers into the country, especially for those who require timely treatments such as cardiac and cancer patients, subject to strict Standard Operating Procedures. Healthcare travellers from China can get more information on how to enter Malaysia for medical treatment by visiting https://www.malaysiahealthcare.cn/.